Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Handl Therapeutics logo — Handl Therapeutics develops gene therapies for complex neuro...

Handl Therapeutics

Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through academic and partner collaborations.

Founded 2019 Belgium Belgium Grant Total: $3.00M Biotechnology, Health Care +1

General Information

Company Name Handl Therapeutics
Founded Year 2019
Location Belgium Belgium
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

Get notified when Handl Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Handl Therapeutics

Handl Therapeutics is a biotechnology startup based in Belgium that is dedicated to developing cutting-edge gene therapies for complex neurodegenerative diseases. Established in 2019, the company's mission is to advance the treatment of these challenging conditions by harnessing the potential of disease-modifying in vivo gene therapy. This approach aims to make a significant impact in the healthcare industry by addressing unmet medical needs. The startup's slogan, "Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through academic and partner collaborations," underscores its focus on collaboration and innovation. Handl Therapeutics operates with a highly integrative business model, leveraging strong relationships with international academic partners and close collaborations with industry peers to drive its therapeutic platform forward. In September 2020, Handl Therapeutics secured a noteworthy investment of €3.00M in the form of a grant from Agentschap Innoveren & Ondernemen. This investment serves as a testament to the confidence that reputable organizations place in the company's vision and potential. Handl Therapeutics' ability to attract financial support and partnerships is indicative of its promise in the biotechnology, healthcare, and pharmaceutical industries.

Taxonomy: Gene Therapy, Neurodegenerative Diseases, Therapeutics, In Vivo Gene Therapy, Drug Development, Collaborations, Academic Partnerships, Medical Innovation, Healthcare Impact, Unmet Medical Needs

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 15 Sep 2020

Handl Therapeutics Alternatives & Competitors

Handl Therapeutics vs
VeonGen Therapeutics GmbH
VeonGen Therapeutics GmbH Germany

Dedicated to develop the medicines of the future

Series A
9 employees
Biotechnology, Health Care
Handl Therapeutics vs
Vivet Therapeutics
Vivet Therapeutics France

Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using liver tropic...

Grant
16 employees
Biopharma, Biotechnology
Handl Therapeutics vs
Tessera Therapeutics
Tessera Therapeutics

Pioneering the future of genetic medicine with the power to rewrite the genome and cure diseases at...

Unknown
21 employees
Biopharma, Biotechnology

FAQ About Handl Therapeutics

Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through academic and partner collaborations.
Handl Therapeutics was founded in 2019.
Handl Therapeutics is headquartered in Belgium.
Handl Therapeutics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Handl Therapeutics has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Grant.
Top alternatives and competitors to Handl Therapeutics include VeonGen Therapeutics GmbH, Vivet Therapeutics, Tessera Therapeutics, Voyager Therapeutics, Inc., Ray Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Handl Therapeutics and VeonGen Therapeutics GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Handl Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy